The reaction of malondialdehyde with lens proteins and the protective effect of aspirin

This publication has 20 references indexed in Scilit:

• Prevention of cataract in diabetic rats by aspirin, paracetamol (acetaminophen) and ibuprofen
  Experimental Eye Research, 1992
• Protection against cataract by aspirin, paracetamol and ibuprofen
  Acta Ophthalmologica, 1989
• Lipid peroxidation and human cataractogenesis in diabetes and severe myopia
  Experimental Eye Research, 1989
• The non-enzymic glycosylation of bovine lens proteins by glucosamine and its inhibition by aspirin, ibuprofen and glutathione
  Experimental Eye Research, 1989
• Lens opacity induced by lipid peroxidation products as a model of cataract associated with retinal disease
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1989
• Dimer and trimer of malonaldehyde
  Journal of the Chemical Society, Perkin Transactions 1, 1989
• DO ASPIRIN-LIKE ANALGESICS PROTECT AGAINST CATARACT?: A Case-control Study
  The Lancet, 1986
• Aspirin prevents carbamylation of soluble lens proteins and prevents cyanate-induced phase separation opacities in vitro: A possible mechanism by which aspirin could prevent cataract
  Experimental Eye Research, 1985
• Synthesis and characterization of the fluorescent products derived from malonaldehyde and amino acids
  Biochemistry, 1969
• CHARACTERIZATION OF THE RED PIGMENT FORMED IN THE 2‐THIOBARBITURIC ACID DETERMINATION OF OXIDATIVE RANCIDITY ^{a, b}
  Journal of Food Science, 1958